Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol
- 15 September 2015
- journal article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 30 (5), 1184-1187
- https://doi.org/10.1038/leu.2015.246
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Chemical genomic screening identifies LY294002 as a modulator of glucocorticoid resistance in MLL-rearranged infant ALLLeukemia, 2013
- Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infantsHaematologica, 2013
- Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemiaLeukemia, 2011
- Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L InhibitorCancer Cell, 2011
- Analysis of the Role of Hematopoietic Stem-Cell Transplantation in Infants With Acute Lymphoblastic Leukemia in First Remission and MLL Gene Rearrangements: A Report From the Children's Oncology GroupJournal of Clinical Oncology, 2011
- Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)–rearranged acute lymphoblastic leukemia: results from the Interfant-99 StudyBlood, 2010
- Outcome of recurrent or refractory acute lymphoblastic leukemia in infants with MLL gene rearrangements: A report from the Japan infant leukemia study groupPediatric Blood & Cancer, 2009
- Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group studyLeukemia, 2008
- Combinations of the FLT3 inhibitor CEP-701 and chemotherapy synergistically kill infant and childhood MLL-rearranged ALL cells in a sequence-dependent mannerLeukemia, 2006
- Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantationBlood, 2004